Document is current
Any future updates will be listed below
-
Authors
Yusufov, Miryam https://orcid.org/0000-0002-0254-3864
Nathan, Margo
Wiley, Aleta
Russell, Julia
Partridge, Ann
Joffe, Hadine
- License Information
-
More Information
Article History
Received: 12 February 2020
Accepted: 1 September 2020
First Online: 12 September 2020
Compliance with ethical standards
:
: Dr. Miryam Yusufov reports in the past 12 months: Consultant: Blue Note Therapeutics. Dr. Hadine Joffe reports in past 12 months: Consultant/Advisory Board: NeRRe/KaNDy, Sojournix, Eisai. Grant/Research Support: National Institutes of Health, Merck, NeRRe/KaNDy, Pfizer, QUE Oncology. Spouse: Merck Research Lab—employee; Arsenal Biosciences—consulting and equity, Tango—equity.
: All participants provided written informed consent for study procedures, which were approved by the Institutional Review Board of Dana-Farber/Harvard Cancer Center (Protocol # 14-206).
: Informed consent was obtained from all individual participants included in the study.
